Wednesday, March 8, 2023

< + > From Limbo To CEO: An Immigrant’s Journey In 3D Bioprinting

For one bioprinting technology company, getting the CEO through the green card maze during the pandemic was the first step toward helping pharmaceutical companies discover and develop new drugs at lower costs.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – July 5, 2026 – 58% of dermatology practices see patients daily with AI-generated diagnoses, 94% of CIOs say AI delays would put their orgs at a competitive disadvantage, plus 27 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...